UnitedHealth shares ‘remain very attractive,’ says Cantor Fitzgerald. Cantor Fitzgerald analyst Steven Halper reiterates an Overweight rating on UnitedHealth with a $300 price target ahead of the company’s Q2 results. The company kicks off the Q2 reporting season on July 17 and should report “strong” results, continuing the trend from Q1, Halper tells investors in a pre-earnings research note
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.